Skip to main content

Table 4 Sensitivity analysis of item totals, median and range, median and range for each level of OAT use (None: n = 88, Partial: n = 32, Complete: n = 75), unadjusted (IRR) and adjusted incidence rate ratios (AIRR) comparing primary healthcare-based medication dispensation across different levels of post-release OAT use among participants who reported any opioid use since baseline interview (N = 195)

From: Is use of opioid agonist treatment associated with broader primary healthcare use among men with recent injecting drug use histories following release from prison? A prospective cohort study

Outcome

Aggregate counta

Median (range)

IRR (95%CI)

p-value

AIRRb (95%CI)

p-value

1. Standard consultations

608

2 (0–30)

    

  OAT: None

138

1 (0–15)

REF

   

  OAT: Partial

127

3.5 (0–19)

2.76 (1.70–4.47)

 < 0.001

2.85 (1.70–4.77)

 < 0.001

  OAT: Complete

343

4 (0–30)

3.39 (2.33–4.94)

 < 0.001

3.52 (2.35–5.27)

 < 0.001

2. Extended consultations

152

0 (0–10)

    

  OAT: None

40

0 (0–10)

REF

   

  OAT: Partial

33

1 (0–4)

2.59 (1.38–4.85)

0.003

2.96 (1.51–5.79)

0.002

  OAT: Complete

79

1 (0–8)

2.75 (1.66–4.54)

 < 0.001

2.85 (1.66–4.89)

 < 0.001

3. Mental health consultations

103

0 (0–7)

    

  OAT: None

24

0 (0–5)

REF

   

  OAT: Partial

27

0 (0–7)

3.26 (1.62–6.58)

0.001

3.13 (1.51–6.49)

0.002

  OAT: Complete

52

0 (0–6)

2.97 (1.66–5.34)

 < 0.001

2.71 (1.45–5.08)

0.002

4. After-hours consultations

73

0 (0–9)

    

  OAT: None

16

0 (0–2)

REF

   

  OAT: Partial

26

0 (0–6)

5.26 (2.46–11.22)

 < 0.001

4.88 (2.12–11.25)

 < 0.001

  OAT: Complete

31

0 (0–9)

2.41 (1.21–4.79)

0.012

1.76 (0.79–3.92)

0.168

5. Pathology items

275

0 (0–26)

    

  OAT: None

75

0 (0–10)

REF

   

  OAT: Partial

37

0 (0–7)

1.52 (0.85–2.72)

0.154

1.49 (0.79–2.82)

0.216

  OAT: Complete

163

0 (0–26)

3.09 (2.02–4.71)

 < 0.001

2.76 (1.67–4.58)

 < 0.001

6. Total prescriptions

925

1 (0–49)

    

  OAT: None

285

0 (0–36)

REF

   

  OAT: Partial

155

2 (0–28)

1.58 (1.00–2.50)

0.050

2.00 (1.21–3.29)

0.007

  OAT: Complete

485

3 (0–49)

2.15 (1.51–3.05)

 < 0.001

2.65 (1.79–3.93)

 < 0.001

7. ATC: nervous system

762

1 (0–49)

    

  OAT: None

206

0 (0–29)

REF

   

  OAT: Partial

135

1.5 (0–27)

1.89 (1.19–3.03)

0.007

2.60 (1.55–4.37)

 < 0.001

  OAT: Complete

421

3 (0–49)

2.60 (1.82–3.73)

 < 0.001

3.61 (2.38–5.47)

 < 0.001

8. ATC: anti-infectives

53

0 (0–4)

    

  OAT: None

29

0 (0–4)

REF

   

  OAT: Partial

9

0 (0–3)

0.93 (0.39–2.21)

0.864

0.92 (0.37–2.32)

0.866

  OAT: Complete

15

0 (0–2)

0.66 (0.33–1.34)

0.252

0.75 (0.34–1.65)

0.474

9. ATC: Alimentary & metabolicc

41

0 (0–6)

    

  OAT: None

18

0 (0–6)

REF

   

  OAT: Partial

2

0 (0–1)

0.31 (0.07–1.43)

0.134

–

–

  OAT: Complete

21

0 (0–4)

1.53 (0.75–3.11)

0.241

–

–

10. ATC: Other

69

0 (0–9)

    

  OAT: None

32

0 (0–9)

REF

   

  OAT: Partial

9

0 (0–4)

0.79 (0.33–1.86)

0.589

0.75 (0.27–2.03)

0.568

  OAT: Complete

28

0 (0–8)

1.07 (0.58–1.95)

0.836

0.87 (0.43–1.78)

0.708

11. Opioids

118

0 (0–17)

    

  OAT: None

73

0 (0–17)

REF

   

  OAT: Partial

10

0 (0–4)

0.37 (0.17–0.83)

0.015

0.60 (0.23–1.55)

0.289

  OAT: Complete

35

0 (0–10)

0.61 (0.36–1.02)

0.059

0.62 (0.31–1.28)

0.197

12. Benzodiazepines

334

0 (0–45)

    

  OAT: None

55

0 (0–25)

REF

   

  OAT: Partial

68

0 (0–27)

3.60 (2.06–6.26)

 < 0.001

4.59 (2.42–8.70)

 < 0.001

  OAT: Complete

211

0 (0–45)

5.35 (3.44–8.32)

 < 0.001

7.19 (4.23–12.20)

 < 0.001

13. Gabapentinoidsd

102

0 (0–14)

    

  OAT: None

16

0 (0–8)

REF

   

  OAT: Partial

33

0 (0–14)

7.05 (3.39–14.69)

 < 0.001

7.13 (3.21–15.86)

 < 0.001

  OAT: Complete

53

0 (0–11)

4.04 (2.11–7.75)

 < 0.001

4.67 (2.32–9.38)

 < 0.001

  1. aBetween date of index release and three-month follow-up; bAdjusted for age at baseline, Aboriginal or Torres Strait Islander, self-reported health status, main drug injected in the preceding 30 days, GHQ-12 score, area of residence, ever diagnosed with a mental illness, ever diagnosed with a chronic health condition, times moved since last interview, accommodation stability and current support worker; cAn adjusted model was not estimated for associations between OAT and Alimentary & Metabolic dispensations due to an insufficient count among people reporting partial OAT; dAdjusted model does not include covariate of main drug injected in the preceding 30 days due to an insufficient cell count in one level of this covariate
Back to article page

Harm Reduction Journal

ISSN: 1477-7517